MDXG
Income statement / Annual
Last year (2023), MiMedx Group, Inc.'s total revenue was $321.48 M,
an increase of 20.03% from the previous year.
In 2023, MiMedx Group, Inc.'s net income was $67.44 M.
See MiMedx Group, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$321.48 M
|
$267.84 M
|
$258.62 M
|
$248.23 M
|
$299.26 M
|
$359.11 M
|
$321.14 M
|
$245.02 M
|
$187.30 M
|
$118.22 M
|
Cost of Revenue |
$54.63 M |
$48.32 M |
$43.28 M |
$39.33 M |
$43.08 M |
$36.39 M |
$35.22 M |
$32.41 M |
$20.20 M |
$12.67 M |
Gross Profit |
$266.84 M |
$219.53 M |
$215.33 M |
$208.90 M |
$256.17 M |
$322.73 M |
$285.92 M |
$212.61 M |
$167.09 M |
$105.56 M |
Gross Profit Ratio |
0.83 |
0.82 |
0.83 |
0.84 |
0.86 |
0.9 |
0.89 |
0.87 |
0.89 |
0.89 |
Research and Development
Expenses |
$12.67 M
|
$22.83 M
|
$17.34 M
|
$11.72 M
|
$11.14 M
|
$15.77 M
|
$17.90 M
|
$12.04 M
|
$8.41 M
|
$7.05 M
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$211.12 M
|
$208.79 M
|
$198.36 M
|
$181.02 M
|
$198.21 M
|
$258.53 M
|
$220.12 M
|
$180.00 M
|
$133.38 M
|
$90.48 M
|
Other Expenses |
-$26,000.00 |
$12.88 M |
$4.61 M |
$60.54 M |
$67.54 M |
$527,000.00 |
-$87,000.00 |
$2.13 M |
$933,000.00 |
$928,000.00 |
Operating Expenses |
$229.73 M |
$244.50 M |
$220.31 M |
$253.28 M |
$276.89 M |
$326.65 M |
$239.70 M |
$194.16 M |
$142.73 M |
$98.46 M |
Cost And Expenses |
$284.36 M |
$292.81 M |
$263.60 M |
$292.61 M |
$319.97 M |
$363.04 M |
$274.92 M |
$226.57 M |
$162.93 M |
$111.12 M |
Interest Income |
$0.00 |
$5.02 M |
$4.98 M |
$7.94 M |
$4.71 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$6.46 M |
$5.02 M |
$4.98 M |
$7.94 M |
-$4.71 M |
$0.00 |
$0.00 |
-$339,000.00 |
$86,000.00 |
$48,000.00 |
Depreciation &
Amortization |
$3.43 M
|
$4.05 M
|
$6.17 M
|
$7.84 M
|
$8.53 M
|
$6.92 M
|
$5.77 M
|
$5.46 M
|
$2.73 M
|
$2.13 M
|
EBITDA |
$40.52 M
|
-$20.93 M
|
$178,000.00
|
-$37.52 M
|
-$12.68 M
|
$2.99 M
|
$53.04 M
|
$23.91 M
|
$27.10 M
|
$9.23 M
|
EBITDA Ratio |
0.13 |
-0.08 |
0 |
-0.15 |
-0.04 |
0.01 |
0.17 |
0.1 |
0.14 |
0.08 |
Operating Income Ratio
|
0.12
|
-0.09
|
-0.02
|
-0.18
|
-0.07
|
-0.01
|
0.14
|
0.08
|
0.13
|
0.06
|
Total Other
Income/Expenses Net |
-$26,000.00
|
-$5.02 M
|
-$5.03 M
|
-$17.17 M
|
-$4.87 M
|
$527,000.00
|
-$1.05 M
|
-$339,000.00
|
-$86,000.00
|
-$48,000.00
|
Income Before Tax |
$30.63 M |
-$29.99 M |
-$10.04 M |
-$61.54 M |
-$25.59 M |
-$3.40 M |
$45.09 M |
$18.11 M |
$24.28 M |
$7.05 M |
Income Before Tax Ratio
|
0.1
|
-0.11
|
-0.04
|
-0.25
|
-0.09
|
-0.01
|
0.14
|
0.07
|
0.13
|
0.06
|
Income Tax Expense |
-$36.81 M |
$206,000.00 |
$247,000.00 |
-$12.26 M |
-$5,000.00 |
$26.58 M |
-$19.64 M |
$6.13 M |
-$5.17 M |
$832,000.00 |
Net Income |
$67.44 M |
-$30.20 M |
-$10.29 M |
-$49.28 M |
-$25.58 M |
-$29.98 M |
$64.73 M |
$11.97 M |
$29.45 M |
$6.22 M |
Net Income Ratio |
0.21 |
-0.11 |
-0.04 |
-0.2 |
-0.09 |
-0.08 |
0.2 |
0.05 |
0.16 |
0.05 |
EPS |
0.4 |
-0.27 |
-0.0932 |
-0.46 |
-0.24 |
-0.28 |
0.61 |
0.0037 |
0.28 |
0.06 |
EPS Diluted |
0.32 |
-0.27 |
-0.0932 |
-0.46 |
-0.24 |
-0.28 |
0.56 |
0.0035 |
0.26 |
0.05 |
Weighted Average Shares
Out |
$116.50 M
|
$112.91 M
|
$110.35 M
|
$108.26 M
|
$106.95 M
|
$105.60 M
|
$106.12 M
|
$105.93 M
|
$105.93 M
|
$105.79 M
|
Weighted Average Shares
Out Diluted |
$145.96 M
|
$112.91 M
|
$110.35 M
|
$108.26 M
|
$106.95 M
|
$105.60 M
|
$116.11 M
|
$112.65 M
|
$113.63 M
|
$113.30 M
|
Link |
|
|
|
|
|
|
|
|
|
|